Volibo (Voglibose) 0.3mg – 100 tablet


Each Volibo contains .3mg Voglibose 100 tablets and is used to lower blood glucose level in patients with Type 2 Diabetes Mellitus

Active Ingrediant: Voglibose
Generic Name: Volibo
Manufacturer: Sun Pharma
Strength: 0.3mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 100 TABLET

Inquire Us

Product Availability (US)

Not available in US


Store at room temperature. Protect from moisture.

Adverse Reactions

Frequency not always defined.
Cardiovascular: Facial edema (<5%)
Central nervous system: Burning sensation (<5%), malaise (<5%), numbness (<5%)
Dermatologic: Alopecia (<5%)

Endocrine & metabolic: Changes in LDH (<5%, increased), decreased HDL cholesterol (<5%), hyperkalemia (<5%), increased alpha-1-antitrypsin (<5%), increased gamma-glutamyl transferase (<5%), hyperammonemia

Gastrointestinal: Abdominal distention (<5%), abdominal pain (<5%), anorexia (<5%), constipation (<5%), diarrhea (<5%), dyspepsia (<5%), flatulence (<5%), heartburn (<5%), increased serum amylase (<5%), loose stools (<5%), nausea (<5%), vomiting (<5%), intestinal obstruction

Hematologic & oncologic: Anemia (<5%)
Hepatic: Increased serum ALT (<5%), increased serum AST (<5%), hepatitis (acute)
Neuromuscular & skeletal: Weakness (<5%)
Ophthalmic: Decreased visual acuity (<5%)
Miscellaneous: Fever (<5%)

<1%, postmarketing, and/or case reports: Delayed gastric emptying, dizziness, drowsiness, dysgeusia, gastritis, headache, hypoglycemia, jaundice, photophobia, pneumatosis cystoides intestinalis, polydipsia, pruritus, severe hepatic insufficiency, skin rash, staggering, stomatitis, thrombocytopenia, tongue ulcer